Vertex Pharmaceuticals’ Casgevy (exagamglogene autotemcel) has continued to show benefits in sickle cell disease (SCD) ...

A researcher at Duke University, speaks out after her NIH grant for sickle cell research was terminated. The $750,000 funding ...

Beam Therapeutics Inc. (NASDAQ:BEAM) ranks among the best CRISPR stocks to buy. On June 13, Beam Therapeutics Inc.

The sickle cell disease treatment market is experiencing significant expansion, driven by increasing disease awareness, rising prevalence, and breakthrough therapies from key pharmaceutical players, ...

Over a hundred sickle cell warriors and their families turned out in support for World Sickle Cell Day at West Oakland’s ...

The condition mostly affects those from African and Caribbean backgrounds but Victoria Ekanoye says it can affect anyone. | ...

Extreme pain, known as a pain crisis, is one of the hallmark symptoms of SCD. With frequent hospitalizations, chronic pain ...

“No single country can defeat sickle cell disease alone. It requires a united effort from governments, research institutions, ...

Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...

In a sharply divided political climate, San Rocco Therapeutics (SRT) has done what few thought possible—earned support from both the highest levels of Washington and from those who distrust it.

The global sickle cell disease treatment market is poised for significant growth, driven by the increasing prevalence of the disease and the demand for effective treatments. North America, led by the ...